Zhao Lin-shuang
About
In The Last Decade
Zhao Lin-shuang
22 papers receiving 410 citations
Peers
Comparison fields: 5 of 63
- Molecular Biology 205
- Physiology 109
- Endocrinology, Diabetes and Metabolism 97
- Cardiology and Cardiovascular Medicine 76
- Oncology 74
Countries citing papers authored by Zhao Lin-shuang
This map shows the geographic impact of Zhao Lin-shuang's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhao Lin-shuang with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhao Lin-shuang more than expected).
Fields of papers citing papers by Zhao Lin-shuang
This network shows the impact of papers produced by Zhao Lin-shuang. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhao Lin-shuang. The network helps show where Zhao Lin-shuang may publish in the future.
Co-authorship network of co-authors of Zhao Lin-shuang
This figure shows the co-authorship network connecting the top 25 collaborators of Zhao Lin-shuang. A scholar is included among the top collaborators of Zhao Lin-shuang based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhao Lin-shuang. Zhao Lin-shuang is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 2 | |
| 2 | 9 | |
| 3 | 81 | |
| 4 | 6 | |
| 5 | 1 | |
| 6 | 9 | |
| 7 | 3 | |
| 8 | 17 | |
| 9 | 3 | |
| 10 | Clinical evaluation of valsartan and metoprolol tartrate in treatment of diabetic nephropathy with positive β1-adrenergic and anti-angiotensin II type 1 receptor antibody. | 7 |
| 11 | [Positive rate of autoantibodies against adrenergic receptors beta1 and angiotensin II type 1 receptors in the type 2 diabetes mellitus with or without hypertension]. | 2 |
| 12 | 25 | |
| 13 | 53 | |
| 14 | [Changes of osteoprotegerin before and after insulin therapy in type 1 diabetic patients]. | 11 |
| 15 | 51 | |
| 16 | 80 | |
| 17 | 9 | |
| 18 | 8 | |
| 19 | 27 | |
| 20 | 9 |
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.